MAP Pharmaceuticals, Inc.
MAP Pharmaceuticals, Inc. (MAPP) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 846 transactions totaling $66.2M, demonstrating a bearish sentiment with -$20.9M in net insider flow. The most recent transaction on Jan 25, 2015 involved a transaction of 1,034 shares valued at $25.6K.
MAPP Insider Activity Summary
Who Is Buying MAPP Stock?
No significant insider buying has been recorded for MAPP in the recent period.
Who Is Selling MAPP Stock?
No significant insider selling has been recorded for MAPP in the recent period.
Is MAP Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MAPP is bearish with an Insider Alignment Score of 34/100 and a net flow of -$20.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
MAPP Frequently Asked Questions
Understanding MAPP Insider Activity
Insider trading at MAP Pharmaceuticals, Inc. (MAPP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading MAPP stock, having executed 846 transactions in the past 90 days. The most active insider is Matthew Mcpherron V (Executive), who has made 4 transactions totaling $83.8M.
Related Tools
Track MAP Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at MAPP file new Form 4 transactions